Xu Zhaomin, Liu Chang, Zhang Chenhao, Gu Miaomiao, Xue Yang, Yang Xibiao, Zhou Yongfang
Department of Respiratory Therapy, West China Hospital of Sichuan University, Chengdu, China.
Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
J Thorac Dis. 2025 Jun 30;17(6):3840-3852. doi: 10.21037/jtd-2024-2140. Epub 2025 Jun 17.
Postoperative pulmonary complications (PPCs) are a leading cause of morbidity and mortality, particularly following thoracic surgeries like lobectomy for lung cancer. These complications not only increase patient suffering but also lead to longer hospital stays and higher healthcare costs. Bronchoscopy, a procedure that enables airway visualization, serves both diagnostic and therapeutic functions. In postoperative care, bronchoscopy helps clear secretions, identify and resolve airway issues, and assess lung re-expansion. This study aimed to investigate whether patients admitted to the intensive care unit (ICU) with routine treatment with bronchoscopy after lobectomy for lung cancer can reduce PPCs, shorten the length of hospital stay, and reduce hospitalization expenses.
This study was a single-center, retrospective cohort study of patients who underwent lobectomy for lung cancer and were subsequently admitted to the ICU between January and December 2021. PPCs, length of hospital stay, and hospitalization expenses were compared between patients treated with bronchoscopy (the bronchoscopy group) and without bronchoscopy (the non-bronchoscopy group). Additionally, the risk factors of postoperative pulmonary complications were analyzed.
A total of 515 patients were included, with 179 patients in the bronchoscopy group and 336 patients in the non-bronchoscopy group. Patients in the bronchoscopy group experienced a higher incidence of PPCs [73 (40.8%) 57 (17.0%); P<0.001], prolonged length of hospital stay [median (interquartile range): 11 (7-14) 7 (5-9.8) days; P<0.001], and higher hospitalization expenses [median (interquartile range): 58,392 (51,248-64,998) 53,563 (48,580-59,276) yuan; P<0.001] than patients in the non-bronchoscopy group. As shown by multifactor logistic regression analysis, postoperative bronchoscopy and tumor size were associated with increased risk of PPCs [odds ratio (OR) 2.71, 95% confidence interval (CI): 1.74-4.21, P<0.001; OR 1.20, 95% CI: 1.05-1.36, P=0.006, respectively], while video-assisted thoracoscopic surgery was associated with a decreased risk (OR 0.22, 95% CI: 0.11-0.45, P<0.001).
Bronchoscopy was associated with a higher risk of PPCs as well as with prolonged hospital stays and increased hospital expenses among postoperative patients who underwent lobectomy for lung cancer. It should be cautiously considered in clinical practice.
术后肺部并发症(PPCs)是发病和死亡的主要原因,尤其是在肺癌肺叶切除等胸科手术后。这些并发症不仅增加患者痛苦,还会导致住院时间延长和医疗费用增加。支气管镜检查是一种能够观察气道的操作,具有诊断和治疗功能。在术后护理中,支气管镜检查有助于清除分泌物、识别和解决气道问题以及评估肺复张情况。本研究旨在调查肺癌肺叶切除术后入住重症监护病房(ICU)并接受支气管镜常规治疗的患者是否能减少PPCs、缩短住院时间并降低住院费用。
本研究是一项单中心回顾性队列研究,研究对象为2021年1月至12月期间接受肺癌肺叶切除术并随后入住ICU的患者。比较了接受支气管镜检查的患者(支气管镜组)和未接受支气管镜检查的患者(非支气管镜组)的PPCs、住院时间和住院费用。此外,还分析了术后肺部并发症的危险因素。
共纳入515例患者,支气管镜组179例,非支气管镜组336例。支气管镜组患者的PPCs发生率更高[73例(40.8%)对57例(17.0%);P<0.001],住院时间延长[中位数(四分位间距):11天(7 - 14天)对7天(5 - 9.8天);P<0.001],住院费用更高[中位数(四分位间距):58392元(51248 - 64998元)对53563元(48580 - 59276元);P<0.001]。多因素逻辑回归分析显示,术后支气管镜检查和肿瘤大小与PPCs风险增加相关[比值比(OR)2.71,95%置信区间(CI):1.74 - 4.21,P<0.001;OR 1.20,95%CI:1.05 - 1.36,P = 0.006],而电视辅助胸腔镜手术与风险降低相关(OR 0.22,95%CI:0.11 - 0.45,P<0.001)。
支气管镜检查与肺癌肺叶切除术后患者发生PPCs的风险较高、住院时间延长和住院费用增加相关。在临床实践中应谨慎考虑。